Cerus (CERS) Income from Continuing Operations (2010 - 2026)
Cerus' (CERS) quarterly Income from Continuing Operations came in at 1648000.0 in Q1 2026, up 78.65% year-on-year from 922487.96 in Q1 2025, and down 110.62% quarter-over-quarter from 15525000.0 in Q4 2025.
Cerus (CERS) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Cerus has disclosed Income from Continuing Operations across 17 years of filings, most recently posting 1648000.0 for Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 1648000.0, up 78.65% year-over-year; the trailing twelve-month figure through Mar 2026 was 8142000.0 (up 141.66% YoY), and the FY2025 annual result was 2072000.0, up 109.63% from the prior year.
- Income from Continuing Operations came in at 1648000.0 for Q1 2026 at Cerus, down from 15525000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 36892000.0 in Q4 2023 to a low of 15641000.0 in Q1 2023.
- The 5-year median for Income from Continuing Operations is 7286000.0 (2023), against an average of 3767294.12.
- Across the five-year window, Income from Continuing Operations plunged 131.52% in 2022 and soared 597.76% in 2025, its largest moves.
- Cerus' Income from Continuing Operations stood at 14384000.0 in 2022, then jumped by 356.48% to 36892000.0 in 2023, then tumbled by 108.45% to 3119000.0 in 2024, then jumped by 597.76% to 15525000.0 in 2025, then sank by 110.62% to 1648000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 1648000.0 (Q1 2026), 15525000.0 (Q4 2025), and 20000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 380.70 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | -1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.65 Mn |
| Dec 31, 2025 | 15.53 Mn |
| Sep 30, 2025 | -20,000.00 |
| Jun 30, 2025 | -5.72 Mn |
| Mar 31, 2025 | -7.72 Mn |
| Dec 31, 2024 | -3.12 Mn |
| Sep 30, 2024 | -2.93 Mn |
| Jun 30, 2024 | -5.78 Mn |
| Mar 31, 2024 | -9.69 Mn |
| Dec 31, 2023 | 36.89 Mn |
| Sep 30, 2023 | -7.29 Mn |
| Jun 30, 2023 | -13.33 Mn |
| Mar 31, 2023 | -15.64 Mn |
| Dec 31, 2022 | -14.38 Mn |
| Sep 30, 2022 | -8.52 Mn |
| Jun 30, 2022 | -8.40 Mn |
| Mar 31, 2022 | -12.28 Mn |
| Dec 31, 2021 | 45.64 Mn |
| Sep 30, 2021 | -12.44 Mn |
| Jun 30, 2021 | -15.36 Mn |